ID   ADCY2_HUMAN             Reviewed;        1091 AA.
AC   Q08462; B7Z2C1; Q2NKL8; Q9UDB2; Q9UPU2;
DT   01-OCT-1994, integrated into UniProtKB/Swiss-Prot.
DT   28-NOV-2006, sequence version 5.
DT   10-MAY-2017, entry version 165.
DE   RecName: Full=Adenylate cyclase type 2;
DE            EC=4.6.1.1 {ECO:0000269|PubMed:15385642};
DE   AltName: Full=ATP pyrophosphate-lyase 2;
DE   AltName: Full=Adenylate cyclase type II;
DE   AltName: Full=Adenylyl cyclase 2;
GN   Name=ADCY2; Synonyms=KIAA1060;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RA   Guo J.H., Yu L.;
RT   "Molecular cloning of human adenylyl cyclase gene.";
RL   Submitted (AUG-2001) to the EMBL/GenBank/DDBJ databases.
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Amygdala;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15372022; DOI=10.1038/nature02919;
RA   Schmutz J., Martin J., Terry A., Couronne O., Grimwood J., Lowry S.,
RA   Gordon L.A., Scott D., Xie G., Huang W., Hellsten U., Tran-Gyamfi M.,
RA   She X., Prabhakar S., Aerts A., Altherr M., Bajorek E., Black S.,
RA   Branscomb E., Caoile C., Challacombe J.F., Chan Y.M., Denys M.,
RA   Detter J.C., Escobar J., Flowers D., Fotopulos D., Glavina T.,
RA   Gomez M., Gonzales E., Goodstein D., Grigoriev I., Groza M.,
RA   Hammon N., Hawkins T., Haydu L., Israni S., Jett J., Kadner K.,
RA   Kimball H., Kobayashi A., Lopez F., Lou Y., Martinez D., Medina C.,
RA   Morgan J., Nandkeshwar R., Noonan J.P., Pitluck S., Pollard M.,
RA   Predki P., Priest J., Ramirez L., Retterer J., Rodriguez A.,
RA   Rogers S., Salamov A., Salazar A., Thayer N., Tice H., Tsai M.,
RA   Ustaszewska A., Vo N., Wheeler J., Wu K., Yang J., Dickson M.,
RA   Cheng J.-F., Eichler E.E., Olsen A., Pennacchio L.A., Rokhsar D.S.,
RA   Richardson P., Lucas S.M., Myers R.M., Rubin E.M.;
RT   "The DNA sequence and comparative analysis of human chromosome 5.";
RL   Nature 431:268-274(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1), AND VARIANT
RP   LEU-147.
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 205-1091 (ISOFORM 1).
RC   TISSUE=Brain;
RX   PubMed=10470851; DOI=10.1093/dnares/6.3.197;
RA   Kikuno R., Nagase T., Ishikawa K., Hirosawa M., Miyajima N.,
RA   Tanaka A., Kotani H., Nomura N., Ohara O.;
RT   "Prediction of the coding sequences of unidentified human genes. XIV.
RT   The complete sequences of 100 new cDNA clones from brain which code
RT   for large proteins in vitro.";
RL   DNA Res. 6:197-205(1999).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 616-1091 (ISOFORM 1).
RC   TISSUE=Brain;
RX   PubMed=1427768; DOI=10.1007/BF00210755;
RA   Stengel D., Parma J., Gannage M.-H., Roeckel N., Mattei M.-G.,
RA   Barouki R., Hanoune J.;
RT   "Different chromosomal localization of two adenylyl cyclase genes
RT   expressed in human brain.";
RL   Hum. Genet. 90:126-130(1992).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 948-1017 (ISOFORM 1), AND TISSUE
RP   SPECIFICITY.
RX   PubMed=8476432; DOI=10.1006/bbrc.1993.1415;
RA   Hellevuo K., Yoshimura M., Kao M., Hoffman P.L., Cooper D.M.F.,
RA   Tabakoff B.;
RT   "A novel adenylyl cyclase sequence cloned from the human
RT   erythroleukemia cell line.";
RL   Biochem. Biophys. Res. Commun. 192:311-318(1993).
RN   [8]
RP   TISSUE SPECIFICITY, AND SUBCELLULAR LOCATION.
RX   PubMed=11549699; DOI=10.1210/jcem.86.9.7837;
RA   Cote M., Guillon G., Payet M.D., Gallo-Payet N.;
RT   "Expression and regulation of adenylyl cyclase isoforms in the human
RT   adrenal gland.";
RL   J. Clin. Endocrinol. Metab. 86:4495-4503(2001).
RN   [9]
RP   FUNCTION, CATALYTIC ACTIVITY, COFACTOR, ENZYME REGULATION,
RP   PHOSPHORYLATION BY RAF1, SUBCELLULAR LOCATION, AND INTERACTION WITH
RP   RAF1.
RX   PubMed=15385642; DOI=10.1124/mol.66.4.;
RA   Ding Q., Gros R., Gray I.D., Taussig R., Ferguson S.S., Feldman R.D.;
RT   "Raf kinase activation of adenylyl cyclases: isoform-selective
RT   regulation.";
RL   Mol. Pharmacol. 66:921-928(2004).
RN   [10]
RP   SUBCELLULAR LOCATION.
RX   PubMed=21228062; DOI=10.1124/jpet.110.177923;
RA   Bogard A.S., Xu C., Ostrom R.S.;
RT   "Human bronchial smooth muscle cells express adenylyl cyclase isoforms
RT   2, 4, and 6 in distinct membrane microdomains.";
RL   J. Pharmacol. Exp. Ther. 337:209-217(2011).
CC   -!- FUNCTION: Catalyzes the formation of the signaling molecule cAMP
CC       in response to G-protein signaling (PubMed:15385642). Down-stream
CC       signaling cascades mediate changes in gene expression patterns and
CC       lead to increased IL6 production. Functions in signaling cascades
CC       downstream of the muscarinic acetylcholine receptors (By
CC       similarity). {ECO:0000250|UniProtKB:P26769,
CC       ECO:0000269|PubMed:15385642}.
CC   -!- CATALYTIC ACTIVITY: ATP = 3',5'-cyclic AMP + diphosphate.
CC       {ECO:0000269|PubMed:15385642}.
CC   -!- COFACTOR:
CC       Name=Mg(2+); Xref=ChEBI:CHEBI:18420;
CC         Evidence={ECO:0000269|PubMed:15385642};
CC       Name=Mn(2+); Xref=ChEBI:CHEBI:29035;
CC         Evidence={ECO:0000269|PubMed:15385642};
CC       Note=Binds 2 magnesium ions per subunit. Is also active with
CC       manganese (in vitro). {ECO:0000250|UniProtKB:P26769};
CC   -!- ENZYME REGULATION: Activated by forskolin (PubMed:15385642). Is
CC       not activated by calmodulin. Inhibited by calcium ions, already at
CC       micromolar concentration. Activated by the G protein alpha subunit
CC       GNAS. Activated by the G protein beta and gamma subunit complex
CC       (By similarity). Phosphorylation by RAF1 results in its activation
CC       (PubMed:15385642). Phosphorylation by PKC activates the enzyme (By
CC       similarity). {ECO:0000250|UniProtKB:P26769,
CC       ECO:0000269|PubMed:15385642}.
CC   -!- SUBUNIT: Interacts with RAF1 (PubMed:15385642). Interacts with
CC       GNAS. Interacts with the G protein beta and gamma subunit complex
CC       (By similarity). {ECO:0000250|UniProtKB:P26769,
CC       ECO:0000269|PubMed:15385642}.
CC   -!- SUBCELLULAR LOCATION: Membrane {ECO:0000269|PubMed:15385642};
CC       Multi-pass membrane protein {ECO:0000305}. Cell membrane
CC       {ECO:0000269|PubMed:11549699, ECO:0000269|PubMed:21228062}; Multi-
CC       pass membrane protein {ECO:0000305}. Cytoplasm
CC       {ECO:0000269|PubMed:11549699}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q08462-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q08462-2; Sequence=VSP_055811, VSP_055812;
CC         Note=No experimental confirmation available.;
CC   -!- TISSUE SPECIFICITY: Detected in zona glomerulosa and zona
CC       fasciculata in the adrenal gland (at protein level)
CC       (PubMed:11549699). Expressed in brain, especially in caudate
CC       nucleus, cerebellum and hippocampus. {ECO:0000269|PubMed:11549699,
CC       ECO:0000269|PubMed:8476432}.
CC   -!- DOMAIN: The protein contains two modules with six transmembrane
CC       helices each; both are required for catalytic activity. Isolated
CC       N-terminal or C-terminal guanylate cyclase domains have no
CC       catalytic activity, but when they are brought together, enzyme
CC       activity is restored. The active site is at the interface of the
CC       two domains. Both contribute substrate-binding residues, but the
CC       catalytic metal ions are bound exclusively via the N-terminal
CC       guanylate cyclase domain. {ECO:0000250|UniProtKB:P26769}.
CC   -!- PTM: Phosphorylated by RAF1. {ECO:0000269|PubMed:15385642}.
CC   -!- SIMILARITY: Belongs to the adenylyl cyclase class-4/guanylyl
CC       cyclase family. {ECO:0000255|PROSITE-ProRule:PRU00099}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF410885; AAP97285.1; -; mRNA.
DR   EMBL; AK294555; BAH11807.1; -; mRNA.
DR   EMBL; AC010346; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC010437; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC024577; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC093305; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC113366; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC111743; AAI11744.1; -; mRNA.
DR   EMBL; AB028983; BAA83012.1; -; mRNA.
DR   EMBL; X74210; CAA52282.1; -; mRNA.
DR   EMBL; L21993; AAA64923.1; -; mRNA.
DR   CCDS; CCDS3872.2; -. [Q08462-1]
DR   PIR; I37136; I37136.
DR   RefSeq; NP_065433.2; NM_020546.2. [Q08462-1]
DR   UniGene; Hs.481545; -.
DR   ProteinModelPortal; Q08462; -.
DR   SMR; Q08462; -.
DR   BioGrid; 106622; 2.
DR   DIP; DIP-422N; -.
DR   IntAct; Q08462; 1.
DR   STRING; 9606.ENSP00000342952; -.
DR   ChEMBL; CHEMBL3760; -.
DR   DrugBank; DB02587; Colforsin.
DR   iPTMnet; Q08462; -.
DR   PhosphoSitePlus; Q08462; -.
DR   BioMuta; ADCY2; -.
DR   DMDM; 118572617; -.
DR   EPD; Q08462; -.
DR   MaxQB; Q08462; -.
DR   PaxDb; Q08462; -.
DR   PeptideAtlas; Q08462; -.
DR   PRIDE; Q08462; -.
DR   Ensembl; ENST00000338316; ENSP00000342952; ENSG00000078295. [Q08462-1]
DR   GeneID; 108; -.
DR   KEGG; hsa:108; -.
DR   UCSC; uc003jdz.2; human. [Q08462-1]
DR   CTD; 108; -.
DR   DisGeNET; 108; -.
DR   GeneCards; ADCY2; -.
DR   HGNC; HGNC:233; ADCY2.
DR   HPA; CAB031482; -.
DR   HPA; HPA038015; -.
DR   HPA; HPA038483; -.
DR   MIM; 103071; gene.
DR   neXtProt; NX_Q08462; -.
DR   OpenTargets; ENSG00000078295; -.
DR   PharmGKB; PA24561; -.
DR   eggNOG; KOG3619; Eukaryota.
DR   eggNOG; COG2114; LUCA.
DR   GeneTree; ENSGT00760000119042; -.
DR   HOGENOM; HOG000006941; -.
DR   HOVERGEN; HBG050458; -.
DR   InParanoid; Q08462; -.
DR   KO; K08042; -.
DR   OMA; QEHSQEP; -.
DR   OrthoDB; EOG091G05JR; -.
DR   PhylomeDB; Q08462; -.
DR   TreeFam; TF313845; -.
DR   BRENDA; 4.6.1.1; 2681.
DR   Reactome; R-HSA-163359; Glucagon signaling in metabolic regulation.
DR   Reactome; R-HSA-163615; PKA activation.
DR   Reactome; R-HSA-164378; PKA activation in glucagon signalling.
DR   Reactome; R-HSA-170660; Adenylate cyclase activating pathway.
DR   Reactome; R-HSA-170670; Adenylate cyclase inhibitory pathway.
DR   Reactome; R-HSA-418555; G alpha (s) signalling events.
DR   Reactome; R-HSA-418594; G alpha (i) signalling events.
DR   Reactome; R-HSA-418597; G alpha (z) signalling events.
DR   Reactome; R-HSA-432040; Vasopressin regulates renal water homeostasis via Aquaporins.
DR   Reactome; R-HSA-5610787; Hedgehog 'off' state.
DR   SIGNOR; Q08462; -.
DR   ChiTaRS; ADCY2; human.
DR   GeneWiki; ADCY2; -.
DR   GenomeRNAi; 108; -.
DR   PRO; PR:Q08462; -.
DR   Proteomes; UP000005640; Chromosome 5.
DR   Bgee; ENSG00000078295; -.
DR   CleanEx; HS_ADCY2; -.
DR   ExpressionAtlas; Q08462; baseline and differential.
DR   Genevisible; Q08462; HS.
DR   GO; GO:0005737; C:cytoplasm; IDA:UniProtKB.
DR   GO; GO:0030425; C:dendrite; ISS:UniProtKB.
DR   GO; GO:0008074; C:guanylate cyclase complex, soluble; IBA:GO_Central.
DR   GO; GO:0005887; C:integral component of plasma membrane; ISS:UniProtKB.
DR   GO; GO:0005622; C:intracellular; ISS:BHF-UCL.
DR   GO; GO:0016020; C:membrane; ISS:UniProtKB.
DR   GO; GO:0045121; C:membrane raft; ISS:BHF-UCL.
DR   GO; GO:0005886; C:plasma membrane; IDA:UniProtKB.
DR   GO; GO:0004016; F:adenylate cyclase activity; ISS:BHF-UCL.
DR   GO; GO:0008179; F:adenylate cyclase binding; ISS:BHF-UCL.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0004383; F:guanylate cyclase activity; IBA:GO_Central.
DR   GO; GO:0000287; F:magnesium ion binding; ISS:UniProtKB.
DR   GO; GO:0030145; F:manganese ion binding; ISS:UniProtKB.
DR   GO; GO:0046982; F:protein heterodimerization activity; ISS:BHF-UCL.
DR   GO; GO:0007190; P:activation of adenylate cyclase activity; TAS:Reactome.
DR   GO; GO:0034199; P:activation of protein kinase A activity; TAS:Reactome.
DR   GO; GO:0007189; P:adenylate cyclase-activating G-protein coupled receptor signaling pathway; ISS:UniProtKB.
DR   GO; GO:0007193; P:adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway; TAS:Reactome.
DR   GO; GO:0007188; P:adenylate cyclase-modulating G-protein coupled receptor signaling pathway; ISS:BHF-UCL.
DR   GO; GO:0006171; P:cAMP biosynthetic process; ISS:BHF-UCL.
DR   GO; GO:0019933; P:cAMP-mediated signaling; ISS:UniProtKB.
DR   GO; GO:1904322; P:cellular response to forskolin; ISS:UniProtKB.
DR   GO; GO:0071377; P:cellular response to glucagon stimulus; TAS:Reactome.
DR   GO; GO:0006182; P:cGMP biosynthetic process; IBA:GO_Central.
DR   GO; GO:0003091; P:renal water homeostasis; TAS:Reactome.
DR   GO; GO:0007165; P:signal transduction; IBA:GO_Central.
DR   Gene3D; 3.30.70.1230; -; 2.
DR   InterPro; IPR001054; A/G_cyclase.
DR   InterPro; IPR018297; A/G_cyclase_CS.
DR   InterPro; IPR032628; AC_N.
DR   InterPro; IPR030672; Adcy.
DR   InterPro; IPR009398; Adcy_conserved_dom.
DR   InterPro; IPR029787; Nucleotide_cyclase.
DR   Pfam; PF16214; AC_N; 1.
DR   Pfam; PF06327; DUF1053; 1.
DR   Pfam; PF00211; Guanylate_cyc; 2.
DR   PIRSF; PIRSF039050; Ade_cyc; 1.
DR   SMART; SM00044; CYCc; 2.
DR   SUPFAM; SSF55073; SSF55073; 2.
DR   PROSITE; PS00452; GUANYLATE_CYCLASE_1; 2.
DR   PROSITE; PS50125; GUANYLATE_CYCLASE_2; 2.
PE   1: Evidence at protein level;
KW   Alternative splicing; ATP-binding; cAMP biosynthesis; Cell membrane;
KW   Complete proteome; Cytoplasm; Glycoprotein; Lyase; Magnesium;
KW   Manganese; Membrane; Metal-binding; Nucleotide-binding;
KW   Phosphoprotein; Polymorphism; Reference proteome; Repeat;
KW   Transmembrane; Transmembrane helix.
FT   CHAIN         1   1091       Adenylate cyclase type 2.
FT                                /FTId=PRO_0000195684.
FT   TOPO_DOM      1     45       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM     46     66       Helical. {ECO:0000255}.
FT   TRANSMEM     76     96       Helical. {ECO:0000255}.
FT   TRANSMEM    108    128       Helical. {ECO:0000255}.
FT   TRANSMEM    133    153       Helical. {ECO:0000255}.
FT   TRANSMEM    159    179       Helical. {ECO:0000255}.
FT   TRANSMEM    187    207       Helical. {ECO:0000255}.
FT   TOPO_DOM    208    601       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    602    622       Helical. {ECO:0000255}.
FT   TRANSMEM    628    652       Helical. {ECO:0000255}.
FT   TRANSMEM    680    701       Helical. {ECO:0000255}.
FT   TRANSMEM    734    755       Helical. {ECO:0000255}.
FT   TRANSMEM    763    780       Helical. {ECO:0000255}.
FT   TRANSMEM    801    821       Helical. {ECO:0000255}.
FT   TOPO_DOM    822   1091       Cytoplasmic. {ECO:0000255}.
FT   NP_BIND     295    300       ATP. {ECO:0000250|UniProtKB:P30803}.
FT   NP_BIND     337    339       ATP. {ECO:0000250|UniProtKB:P30803}.
FT   NP_BIND    1019   1021       ATP. {ECO:0000250|UniProtKB:P26769}.
FT   NP_BIND    1026   1030       ATP. {ECO:0000250|UniProtKB:P26769}.
FT   REGION      905    922       Interaction with GNAS.
FT                                {ECO:0000250|UniProtKB:P26769}.
FT   REGION      990    993       Interaction with GNAS.
FT                                {ECO:0000250|UniProtKB:P26769}.
FT   METAL       295    295       Magnesium 1; catalytic.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00099}.
FT   METAL       295    295       Magnesium 2; catalytic.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00099}.
FT   METAL       296    296       Magnesium 2; via carbonyl oxygen;
FT                                catalytic. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00099}.
FT   METAL       339    339       Magnesium 1; catalytic.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00099}.
FT   METAL       339    339       Magnesium 2; catalytic.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00099}.
FT   BINDING     383    383       ATP. {ECO:0000250|UniProtKB:P30803}.
FT   BINDING     939    939       ATP. {ECO:0000250|UniProtKB:P26769}.
FT   BINDING    1066   1066       ATP. {ECO:0000250|UniProtKB:P26769}.
FT   MOD_RES     491    491       Phosphoserine; by PKC.
FT                                {ECO:0000250|UniProtKB:P26769}.
FT   MOD_RES     544    544       Phosphoserine; by PKC.
FT                                {ECO:0000250|UniProtKB:P26769}.
FT   CARBOHYD    713    713       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    716    716       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   VAR_SEQ       1     59       MWQEAMRRRRYLRDRSEEAAGGGDGLPRSRDWLYESYYCMS
FT                                QQHPLIVFLLLIVMGSCL -> MDLRWARDLHLREASRSVA
FT                                FTTLRLGAVTTGLLTFREPGDKEKSGKGLGKRWRIQREES
FT                                (in isoform 2).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_055811.
FT   VAR_SEQ      60    239       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_055812.
FT   VARIANT     147    147       V -> L (in dbSNP:rs13166360).
FT                                {ECO:0000269|PubMed:15489334}.
FT                                /FTId=VAR_029012.
FT   VARIANT     163    163       V -> I (in dbSNP:rs34043481).
FT                                /FTId=VAR_048247.
FT   CONFLICT    188    207       VWQILANVIIFICGNLAGAY -> GLADPGQCDHFHLWEPG
FT                                XTN (in Ref. 1; AAP97285). {ECO:0000305}.
FT   CONFLICT    675    675       R -> Q (in Ref. 6; CAA52282/AAA64923).
FT                                {ECO:0000305}.
SQ   SEQUENCE   1091 AA;  123603 MW;  41FD8BC607C075D1 CRC64;
     MWQEAMRRRR YLRDRSEEAA GGGDGLPRSR DWLYESYYCM SQQHPLIVFL LLIVMGSCLA
     LLAVFFALGL EVEDHVAFLI TVPTALAIFF AIFILVCIES VFKKLLRLFS LVIWICLVAM
     GYLFMCFGGT VSPWDQVSFF LFIIFVVYTM LPFNMRDAII ASVLTSSSHT IVLSVCLSAT
     PGGKEHLVWQ ILANVIIFIC GNLAGAYHKH LMELALQQTY QDTCNCIKSR IKLEFEKRQQ
     ERLLLSLLPA HIAMEMKAEI IQRLQGPKAG QMENTNNFHN LYVKRHTNVS ILYADIVGFT
     RLASDCSPGE LVHMLNELFG KFDQIAKENE CMRIKILGDC YYCVSGLPIS LPNHAKNCVK
     MGLDMCEAIK KVRDATGVDI NMRVGVHSGN VLCGVIGLQK WQYDVWSHDV TLANHMEAGG
     VPGRVHISSV TLEHLNGAYK VEEGDGDIRD PYLKQHLVKT YFVINPKGER RSPQHLFRPR
     HTLDGAKMRA SVRMTRYLES WGAAKPFAHL HHRDSMTTEN GKISTTDVPM GQHNFQNRTL
     RTKSQKKRFE EELNERMIQA IDGINAQKQW LKSEDIQRIS LLFYNKVLEK EYRATALPAF
     KYYVTCACLI FFCIFIVQIL VLPKTSVLGI SFGAAFLLLA FILFVCFAGQ LLQCSKKASP
     LLMWLLKSSG IIANRPWPRI SLTIITTAII LMMAVFNMFF LSDSEETIPP TANTTNTSFS
     ASNNQVAILR AQNLFFLPYF IYSCILGLIS CSVFLRVNYE LKMLIMMVAL VGYNTILLHT
     HAHVLGDYSQ VLFERPGIWK DLKTMGSVSL SIFFITLLVL GRQNEYYCRL DFLWKNKFKK
     EREEIETMEN LNRVLLENVL PAHVAEHFLA RSLKNEELYH QSYDCVCVMF ASIPDFKEFY
     TESDVNKEGL ECLRLLNEII ADFDDLLSKP KFSGVEKIKT IGSTYMAATG LSAVPSQEHS
     QEPERQYMHI GTMVEFAFAL VGKLDAINKH SFNDFKLRVG INHGPVIAGV IGAQKPQYDI
     WGNTVNVASR MDSTGVLDKI QVTEETSLVL QTLGYTCTCR GIINVKGKGD LKTYFVNTEM
     SRSLSQSNVA S
//
